https://www.selleckchem.com/products/scr7.html
The C HEST score has been validated for predicting AF in the general population or post-stroke patients. We aimed to assess whether this risk score could predict incident AF and other clinical outcomes in heart failure with preserved ejection fraction (HFpEF) patients. A total of 2202 HFpEF patients without baseline AF in the TOPCAT trial were stratified by baseline C HEST score. Cox proportional hazard model and competing risk regression model was used to explore the relationship between C HEST score and outcomes, including incident AF, s
Me gusta
Comentario
Compartir
